These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 10694577)

  • 21. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis.
    Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model.
    Huynh TV; Wang C; Tran AC; Tabor GT; Mahan TE; Francis CM; Finn MB; Spellman R; Manis M; Tanzi RE; Ulrich JD; Holtzman DM
    Mol Neurodegener; 2019 Oct; 14(1):37. PubMed ID: 31623648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
    Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
    Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice.
    Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R
    Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
    Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
    Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice.
    Pankiewicz JE; Baquero-Buitrago J; Sanchez S; Lopez-Contreras J; Kim J; Sullivan PM; Holtzman DM; Sadowski MJ
    Mol Neurodegener; 2017 Jan; 12(1):12. PubMed ID: 28143566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human apolipoprotein E2 promotes parenchymal amyloid deposition and neuronal loss in vasculotropic mutant amyloid-β protein Tg-SwDI mice.
    Xu F; Vitek MP; Colton CA; Previti ML; Davis J; Van Nostrand WE
    J Alzheimers Dis; 2012; 31(2):359-69. PubMed ID: 22635103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis.
    Kim J; Jiang H; Park S; Eltorai AE; Stewart FR; Yoon H; Basak JM; Finn MB; Holtzman DM
    J Neurosci; 2011 Dec; 31(49):18007-12. PubMed ID: 22159114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
    Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM
    Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction With N-terminal Amyloid Precursor Protein, Reduces β-Amyloid-Associated Pathology, and Improves Cognition.
    Sawmiller D; Habib A; Hou H; Mori T; Fan A; Tian J; Zeng J; Giunta B; Sanberg PR; Mattson MP; Tan J
    Biol Psychiatry; 2019 Aug; 86(3):208-220. PubMed ID: 31208706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
    Katsouri L; Georgopoulos S
    PLoS One; 2011; 6(7):e21880. PubMed ID: 21755005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ApoE facilitates the microglial response to amyloid plaque pathology.
    Ulrich JD; Ulland TK; Mahan TE; Nyström S; Nilsson KP; Song WM; Zhou Y; Reinartz M; Choi S; Jiang H; Stewart FR; Anderson E; Wang Y; Colonna M; Holtzman DM
    J Exp Med; 2018 Apr; 215(4):1047-1058. PubMed ID: 29483128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage-mediated degradation of beta-amyloid via an apolipoprotein E isoform-dependent mechanism.
    Zhao L; Lin S; Bales KR; Gelfanova V; Koger D; Delong C; Hale J; Liu F; Hunter JM; Paul SM
    J Neurosci; 2009 Mar; 29(11):3603-12. PubMed ID: 19295164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE Antibody Inhibits Aβ-Associated Tau Seeding and Spreading in a Mouse Model.
    Gratuze M; Jiang H; Wang C; Xiong M; Bao X; Holtzman DM
    Ann Neurol; 2022 Jun; 91(6):847-852. PubMed ID: 35285073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of Synthetic Aβ to In Vivo Active Seeds and Amyloid Plaque Formation in a Hippocampal Slice Culture Model.
    Novotny R; Langer F; Mahler J; Skodras A; Vlachos A; Wegenast-Braun BM; Kaeser SA; Neher JJ; Eisele YS; Pietrowski MJ; Nilsson KP; Deller T; Staufenbiel M; Heimrich B; Jucker M
    J Neurosci; 2016 May; 36(18):5084-93. PubMed ID: 27147660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOE-ε4 synergizes with sleep disruption to accelerate Aβ deposition and Aβ-associated tau seeding and spreading.
    Wang C; Nambiar A; Strickland MR; Lee C; Parhizkar S; Moore AC; Musiek ES; Ulrich JD; Holtzman DM
    J Clin Invest; 2023 Jul; 133(14):. PubMed ID: 37279069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
    Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
    Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.